Journal article
A multiplex platform for the identification of ovarian cancer biomarkers
Abstract
BackgroundCurrently, there are no FDA approved screening tools for detecting early stage ovarian cancer in the general population. Development of a biomarker-based assay for early detection would significantly improve the survival of ovarian cancer patients.
MethodsWe used a multiplex approach to identify protein biomarkers for detecting early stage ovarian cancer. This new technology (Proseek® Multiplex Oncology Plates) can simultaneously …
Authors
Boylan KLM; Geschwind K; Koopmeiners JS; Geller MA; Starr TK; Skubitz APN
Journal
Clinical Proteomics, Vol. 14, No. 1,
Publisher
Springer Nature
Publication Date
12 2017
DOI
10.1186/s12014-017-9169-6
ISSN
1542-6416